With a market cap of $69.7 billion, Boston Scientific Corporation (BSX) is a global medical technology leader focused on developing innovative solutions that improve patient health and transform lives. The company offers a broad portfolio of high-performance devices and therapies designed to address unmet medical needs while helping reduce healthcare costs.
Companies valued at more than $10 billion are generally considered “large-cap” stocks, and Boston Scientific fits this criterion perfectly. Its technologies support physicians in diagnosing and treating complex cardiovascular, respiratory, digestive, oncological, neurological, and urological conditions.